Australia markets closed

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.06800.0000 (0.00%)
At close: 10:06AM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Operating expenses
Research development
24,031
24,031
14,004
-
-
Selling general and administrative
4,380
4,380
6,176
5,671
1,828
Total operating expenses
30,208
30,208
21,833
9,745
7,102
Operating income or loss
-30,208
-30,208
-21,833
-9,745
-7,102
Interest expense
32.595
32.595
38.822
-
-
Total other income/expenses net
15,922
15,922
3,133
62.5
0.25
Income before tax
-14,294
-14,294
-18,630
-9,475
-6,984
Income tax expense
0
0
0
-2,396
-2,904
Income from continuing operations
-14,294
-14,294
-18,630
-7,080
-4,080
Net income
-13,863
-13,863
-17,768
-6,822
-4,080
Net income available to common shareholders
-13,863
-13,863
-17,768
-6,822
-4,080
Basic EPS
-
-
-0.01
-0.00
-0.00
Diluted EPS
-
-
-0.01
-0.00
-0.00
Basic average shares
-
-
3,091,647
2,641,766
2,455,400
Diluted average shares
-
-
3,091,647
2,641,766
2,455,400
EBITDA
-
-13,422
-17,969
-9,198
-6,972